Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Total Current Liabilities (2020 - 2025)

Historic Total Current Liabilities for MDxHealth (MDXH) over the last 6 years, with Q3 2025 value amounting to $51.2 million.

  • MDxHealth's Total Current Liabilities rose 1233.83% to $51.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $51.2 million, marking a year-over-year increase of 1233.83%. This contributed to the annual value of $42.7 million for FY2024, which is 11852.69% up from last year.
  • MDxHealth's Total Current Liabilities amounted to $51.2 million in Q3 2025, which was up 1233.83% from $48.5 billion recorded in Q2 2025.
  • MDxHealth's 5-year Total Current Liabilities high stood at $48.5 billion for Q2 2025, and its period low was $16.4 million during Q4 2021.
  • Its 5-year average for Total Current Liabilities is $3.5 billion, with a median of $31.2 million in 2022.
  • As far as peak fluctuations go, MDxHealth's Total Current Liabilities tumbled by 221.01% in 2023, and later soared by 10766903.94% in 2025.
  • Over the past 5 years, MDxHealth's Total Current Liabilities (Quarter) stood at $16.4 million in 2021, then grew by 11.23% to $18.3 million in 2022, then increased by 6.81% to $19.5 million in 2023, then soared by 118.53% to $42.7 million in 2024, then grew by 19.92% to $51.2 million in 2025.
  • Its Total Current Liabilities stands at $51.2 million for Q3 2025, versus $48.5 billion for Q2 2025 and $43.2 million for Q1 2025.